Medical Properties Trust (NYSE:MPW) Given New $6.00 Price Target at Truist Financial

Medical Properties Trust (NYSE:MPW) had its price objective boosted by Truist Financial from $5.00 to $6.00 in a report issued on Friday morning, Benzinga reports. Truist Financial currently has a hold rating on the real estate investment trust’s stock.

Other equities research analysts have also issued reports about the company. BNP Paribas lowered Medical Properties Trust from an outperform rating to a neutral rating and dropped their price target for the company from $6.00 to $4.00 in a research report on Tuesday, July 2nd. Colliers Securities upgraded shares of Medical Properties Trust from a neutral rating to a buy rating and set a $6.50 price target on the stock in a research report on Friday. Finally, StockNews.com downgraded shares of Medical Properties Trust from a hold rating to a sell rating in a research report on Saturday, May 18th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat, Medical Properties Trust currently has a consensus rating of Hold and an average target price of $5.22.

Medical Properties Trust Trading Up 13.8 %

NYSE MPW opened at $6.37 on Friday. The company has a market capitalization of $3.82 billion, a price-to-earnings ratio of -2.87, a price-to-earnings-growth ratio of 0.68 and a beta of 1.28. The company has a debt-to-equity ratio of 1.51, a current ratio of 2.93 and a quick ratio of 2.93. Medical Properties Trust has a 12 month low of $2.92 and a 12 month high of $6.64. The company’s fifty day moving average price is $4.76 and its two-hundred day moving average price is $4.68.

Medical Properties Trust (NYSE:MPW) last issued its quarterly earnings results on Thursday, August 8th. The real estate investment trust reported ($0.54) EPS for the quarter, missing the consensus estimate of $0.21 by ($0.75). The firm had revenue of $266.60 million for the quarter, compared to analyst estimates of $259.53 million. The business’s revenue was down 21.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.48 earnings per share. As a group, research analysts predict that Medical Properties Trust will post 0.89 earnings per share for the current fiscal year.

Medical Properties Trust Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 10th. Stockholders of record on Monday, September 9th will be issued a dividend of $0.08 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $0.32 dividend on an annualized basis and a dividend yield of 5.02%. Medical Properties Trust’s dividend payout ratio (DPR) is presently -14.41%.

Insider Transactions at Medical Properties Trust

In other Medical Properties Trust news, Director C Reynolds Thompson III sold 20,530 shares of Medical Properties Trust stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $4.38, for a total transaction of $89,921.40. Following the sale, the director now owns 54,637 shares of the company’s stock, valued at approximately $239,310.06. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Medical Properties Trust news, Director C Reynolds Thompson III sold 20,530 shares of the firm’s stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $4.38, for a total transaction of $89,921.40. Following the transaction, the director now owns 54,637 shares of the company’s stock, valued at approximately $239,310.06. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Elizabeth N. Pitman sold 10,025 shares of the company’s stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $4.98, for a total transaction of $49,924.50. Following the completion of the sale, the director now directly owns 68,653 shares of the company’s stock, valued at $341,891.94. The disclosure for this sale can be found here. Insiders own 1.53% of the company’s stock.

Hedge Funds Weigh In On Medical Properties Trust

Several hedge funds have recently modified their holdings of the company. International Assets Investment Management LLC lifted its stake in Medical Properties Trust by 19.4% during the fourth quarter. International Assets Investment Management LLC now owns 170,283 shares of the real estate investment trust’s stock valued at $836,000 after purchasing an additional 27,710 shares during the last quarter. Truist Financial Corp boosted its stake in shares of Medical Properties Trust by 12.0% during the 4th quarter. Truist Financial Corp now owns 97,955 shares of the real estate investment trust’s stock worth $481,000 after acquiring an additional 10,476 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Medical Properties Trust by 5.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 9,058,339 shares of the real estate investment trust’s stock worth $44,476,000 after acquiring an additional 448,118 shares during the last quarter. Principal Securities Inc. acquired a new stake in shares of Medical Properties Trust during the fourth quarter worth $50,000. Finally, BNP Paribas Financial Markets lifted its holdings in shares of Medical Properties Trust by 517.0% during the fourth quarter. BNP Paribas Financial Markets now owns 2,150,378 shares of the real estate investment trust’s stock valued at $10,558,000 after purchasing an additional 1,801,858 shares during the last quarter. 71.79% of the stock is currently owned by institutional investors and hedge funds.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.